BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun J, Aghemo A, Forner A, Valenti L. COVID-19 and liver disease. Liver Int. 2020;40:1278-1281. [PMID: 32251539 DOI: 10.1111/liv.14470] [Cited by in Crossref: 119] [Cited by in F6Publishing: 110] [Article Influence: 59.5] [Reference Citation Analysis]
Number Citing Articles
1 Liaquat H, Shupp B, Rollins S, Schneider Y, Matin A. Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease. Sci Rep 2021;11:19245. [PMID: 34584170 DOI: 10.1038/s41598-021-98778-z] [Reference Citation Analysis]
2 Aydin A, Cebi G, Demirtas ZE, Erkus H, Kucukay A, Ok M, Sakalli L, Alpdagtas S, Gunduz O, Ustundag CB. Combating COVID-19 with tissue engineering: a review. Emergent Mater 2020;:1-21. [PMID: 33235976 DOI: 10.1007/s42247-020-00138-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu D, Rao Q, Zhang W. The natural course of COVID-19 patients without clinical intervention. J Med Virol 2021;93:5527-37. [PMID: 33990975 DOI: 10.1002/jmv.27087] [Reference Citation Analysis]
4 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lv XH, Yang JL, Deng K. Letter to the Editor: COVID-19-Related Liver Injury: The Interpretation for Aspartate Aminotransferase Needs to Be Cautious. Hepatology 2021;73:874. [PMID: 32767788 DOI: 10.1002/hep.31509] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, Zhao K, Ouyang S. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021;18:121. [PMID: 34108015 DOI: 10.1186/s12985-021-01593-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig Liver Dis. 2021;53:146-152. [PMID: 32988758 DOI: 10.1016/j.dld.2020.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
8 Garland V, Kumar AB, Borum ML. Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations. J Natl Med Assoc. 2021;113:142-146. [PMID: 32807512 DOI: 10.1016/j.jnma.2020.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Kardani K, Bolhassani A, Kardani M, Agi E; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. JoMMID 2021;9:122-32. [DOI: 10.52547/jommid.9.3.122] [Reference Citation Analysis]
11 Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699 [PMID: 34629794 DOI: 10.3748/wjg.v27.i34.5682] [Reference Citation Analysis]
12 Nalugo M, Schulte LJ, Masood MF, Zayed MA. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med 2021;8:636843. [PMID: 33604359 DOI: 10.3389/fcvm.2021.636843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Frater JL, Wang T, Lee Y. Laboratory hematologic features of COVID-19 associated liver injury: A systematic review. WJMA 2021;9:192-206. [DOI: 10.13105/wjma.v9.i2.192] [Reference Citation Analysis]
14 Paliogiannis P, Zinellu A. Bilirubin levels in patients with mild and severe Covid-19: A pooled analysis. Liver Int. 2020;40:1787-1788. [PMID: 32304343 DOI: 10.1111/liv.14477] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
15 Mnatsakanyan MG, Pogromov AP, Lishuta AS, Fomin VV, Volkova OS, Tashchyan OV, Kuprina IV, Shumskaya YF. Liver and COVID-19: possible mechanisms of damage. Terapevticheskii arkhiv 2021;93:427-30. [DOI: 10.26442/00403660.2021.04.200733] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Reddy KR. SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections. Clin Liver Dis (Hoboken) 2020;15:191-4. [PMID: 32489654 DOI: 10.1002/cld.970] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
17 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Reference Citation Analysis]
18 Taneva G, Dimitrov D, Velikova T. Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19. World J Hepatol 2021; 13(12): 2005-2012 [DOI: 10.4254/wjh.v13.i12.2005] [Reference Citation Analysis]
19 Maxwell AJ, Ding J, You Y, Dong Z, Chehade H, Alvero A, Mor Y, Draghici S, Mor G. Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients. J Leukoc Biol 2021;109:35-47. [PMID: 33242368 DOI: 10.1002/JLB.4COVR0920-552RR] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
20 El-Ghiaty MA, Shoieb SM, El-Kadi AOS. Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms. Med Hypotheses 2020;144:110033. [PMID: 32758877 DOI: 10.1016/j.mehy.2020.110033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
21 Papadopoulos N, Vasileiadi S, Deutsch M. COVID-19 and liver injury: where do we stand? Ann Gastroenterol 2020;33:459-64. [PMID: 32879591 DOI: 10.20524/aog.2020.0522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Verma HK, Bhaskar L. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted. World J Gastroenterol 2021; 27(45): 7855-7858 [PMID: 34963747 DOI: 10.3748/wjg.v27.i45.7855] [Reference Citation Analysis]
23 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
24 Ye L, Chen B, Wang Y, Yang Y, Zeng J, Deng G, Deng Y, Zeng F. Prognostic value of liver biochemical parameters for COVID-19 mortality. Ann Hepatol. 2021;21:100279. [PMID: 33157267 DOI: 10.1016/j.aohep.2020.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sagnelli C, Macera M, Camaioni C, Salvati A, Coppola N, Sagnelli E. SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis. Infection 2022. [PMID: 35316530 DOI: 10.1007/s15010-022-01804-z] [Reference Citation Analysis]
26 Amere Subbarao S. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting. Inflammopharmacology 2021;29:343-66. [PMID: 33723711 DOI: 10.1007/s10787-021-00796-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations. EPMA J 2020;11:505-15. [PMID: 32839667 DOI: 10.1007/s13167-020-00221-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
28 Araç S, Özel M. A new parameter for predict the clinical outcome of patients with COVID-19 pneumonia: The direct/total bilirubin ratio. Int J Clin Pract 2021;:e14557. [PMID: 34157182 DOI: 10.1111/ijcp.14557] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Wiśniewska H, Skonieczna-Żydecka K, Parczewski M, Niścigorska-Olsen J, Karpińska E, Hornung M, Jurczyk K, Witak-Jędra M, Laurans Ł, Maciejewska K, Socha Ł, Leonciuk A, Bander D, Karasińska-Cieślak M, Aksak-Wąs B, Wawrzynowicz-Syczewska M. Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic. J Clin Med 2021;10:672. [PMID: 33572429 DOI: 10.3390/jcm10040672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Cheah IK, Halliwell B. Could Ergothioneine Aid in the Treatment of Coronavirus Patients? Antioxidants (Basel) 2020;9:E595. [PMID: 32646061 DOI: 10.3390/antiox9070595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
31 Zhu DD, Tan XM, Lu LQ, Yu SJ, Jian RL, Liang XF, Liao YX, Fan W, Barbier-Torres L, Yang A, Yang HP, Liu T. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. World J Gastroenterol 2021; 27(22): 2944-2962 [PMID: 34168400 DOI: 10.3748/wjg.v27.i22.2944] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Mori M, Ikeda N, Taketomi A, Asahi Y, Takesue Y, Orimo T, Ono M, Kuwayama T, Nakamura S, Yamada Y, Kuroda T, Yuzawa K, Hibi T, Nagano H, Unno M, Kitagawa Y. COVID-19: clinical issues from the Japan Surgical Society. Surg Today 2020;50:794-808. [PMID: 32651686 DOI: 10.1007/s00595-020-02047-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
33 Coni P, Pichiri G, Lachowicz JI, Ravarino A, Ledda F, Fanni D, Gerosa C, Piras M, Coghe F, Gibo Y, Cau F, Castagnola M, Van Eyken P, Saba L, Piludu M, Faa G. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. Molecules 2021;26:6614. [PMID: 34771023 DOI: 10.3390/molecules26216614] [Reference Citation Analysis]
34 Siniscalchi A, Vitale G, Morelli MC, Ravaioli M, Laici C, Bianchini A, Del Gaudio M, Conti F, Vizioli L, Cescon M. Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipients. Intern Emerg Med. 2020;15:1507-1515. [PMID: 32979193 DOI: 10.1007/s11739-020-02511-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Sadeghi A, Eslami P, Dooghaie Moghadam A, Pirsalehi A, Shojaee S, Jalilian Khave L, Sanadgol G, Hasanzade T, Shirini D, Asadzadeh Aghdaei H, Abdi S, Zali MR. Risk factors related to liver injury in non-Intensive Care Unit admitted patients infected with COVID-19: A retrospective study of 102 patients. Caspian J Intern Med. 2020;11:520-526. [PMID: 33425269 DOI: 10.22088/cjim.11.0.520] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Cho SI, Yoon S, Lee HJ. Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database. Sci Rep 2021;11:6375. [PMID: 33737679 DOI: 10.1038/s41598-021-85813-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
37 Mamedov T, Yuksel D, Ilgın M, Gurbuzaslan I, Gulec B, Yetiskin H, Uygut MA, Islam Pavel ST, Ozdarendeli A, Mammadova G, Say D, Hasanova G. Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice. Viruses 2021;13:1595. [PMID: 34452461 DOI: 10.3390/v13081595] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Bianco C, Baselli G, Malvestiti F, Santoro L, Pelusi S, Manunta M, Grasselli G, Bandera A, Scudeller L, Prati D, Valenti L. Genetic insight into COVID‐19‐related liver injury. Liver Int 2021;41:227-9. [DOI: 10.1111/liv.14708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
39 Liu J, Li S, Zhou H, Hu C, Yue Z, Lv G. Clinical Characteristics and Laboratory Testing of Patients With COVID19: A Retrospective Analysis. acupunct electrother res 2021;47:81-90. [DOI: 10.3727/036012921x16287835103471] [Reference Citation Analysis]
40 Miele L, Napodano C, Cesario A, De Magistris A, Pocino K, Basile U, Rapaccini GL, Gasbarrini A, Grieco A. COVID-19, adaptative immune response and metabolic-associated liver disease. Liver Int 2021;41:2560-77. [PMID: 34555255 DOI: 10.1111/liv.15061] [Reference Citation Analysis]
41 Spogis J, Hagen F, Thaiss WM, Hoffmann T, Malek N, Nikolaou K, Berg CP, Singer S, Bösmüller H, Kreth F, Kaufmann S. Sonographic findings in coronavirus disease-19 associated liver damage. PLoS One 2021;16:e0244781. [PMID: 33606703 DOI: 10.1371/journal.pone.0244781] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Kidson KM, Park J, Charles MK, Omar M, Krajden M, Wright AJ, Hussaini T, Kim PTW, Chung SW, Yoshida EM. Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report. Transplant Direct 2021;7:e747. [PMID: 34476292 DOI: 10.1097/TXD.0000000000001210] [Reference Citation Analysis]
43 Valenti L, Jamialahmadi O, Romeo S. Lack of genetic evidence that fatty liver disease predisposes to COVID-19. J Hepatol. 2020;73:709-711. [PMID: 32445883 DOI: 10.1016/j.jhep.2020.05.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
44 Fiel MI, El Jamal SM, Paniz-Mondolfi A, Gordon RE, Reidy J, Bandovic J, Advani R, Kilaru S, Pourmand K, Ward S, Thung SN, Schiano T. Findings of Severe Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection. Cell Mol Gastroenterol Hepatol. 2021;1-8. [PMID: 32992052 DOI: 10.1016/j.jcmgh.2020.09.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
45 Saracco M, Martini S, Tandoi F, Dell'Olio D, Ottobrelli A, Scarmozzino A, Amoroso A, Fonio P, Balagna R, Romagnoli R. Carrying on with liver transplantation during the COVID-19 emergency: Report from piedmont region. Clin Res Hepatol Gastroenterol. 2020;101512. [PMID: 32859555 DOI: 10.1016/j.clinre.2020.07.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Afaghi P, Lapolla MA, Ghandi K. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021;7:e06454. [PMID: 33748501 DOI: 10.1016/j.heliyon.2021.e06454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Lee YR, Kang MK, Song JE, Kim HJ, Kweon YO, Tak WY, Jang SY, Park JG, Lee C, Hwang JS, Jang BK, Suh JI, Chung WJ, Kim BS, Park SY. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. Clin Mol Hepatol. 2020;26:562-576. [PMID: 33053932 DOI: 10.3350/cmh.2020.0126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
48 Mohammed SA, Eid KM, Anyiam FE, Wadaaallah H, Muhamed MAM, Morsi MH, Dahman NBH. Liver injury with COVID-19: laboratory and histopathological outcome—systematic review and meta-analysis. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00171-6] [Reference Citation Analysis]
49 Currier EE, Dabaja M, Jafri SM. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2. World J Hepatol 2021; 13(9): 1181-1189 [PMID: 34630884 DOI: 10.4254/wjh.v13.i9.1181] [Reference Citation Analysis]
50 Villar LM, de Paula VS, Pinto LCM, Marques BCL, da Costa VD, da Silva LL, Santos AC, do Nascimento GP, Miguel JC, Mendonça ACDF, Motta FC, Lewis-Ximenez LL. Clinical and laboratory characteristics of hepatitis C and COVID-19 coinfection: Prolonged RNA shedding in nonhospitalized case. Clin Case Rep 2021. [PMID: 34178330 DOI: 10.1002/ccr3.3877] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Philips CA, Mohan N, Ahamed R, Kumbar S, Rajesh S, George T, Mohanan M, Augustine P. One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease. World J Clin Cases 2020; 8(18): 3956-3970 [PMID: 33024752 DOI: 10.12998/wjcc.v8.i18.3956] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
52 Pitlik SD. COVID-19 Compared to Other Pandemic Diseases. Rambam Maimonides Med J 2020;11. [PMID: 32792043 DOI: 10.5041/RMMJ.10418] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
53 Galiero R, Pafundi PC, Simeon V, Rinaldi L, Perrella A, Vetrano E, Caturano A, Alfano M, Beccia D, Nevola R, Marfella R, Sardu C, Coppola C, Scarano F, Maggi P, De Lucia Sposito P, Vocciante L, Rescigno C, Sbreglia C, Fraganza F, Parrella R, Romano A, Calabria G, Polverino B, Pagano A, Bologna C, Amitrano M, Esposito V, Coppola N, Maturo N, Adinolfi LE, Chiodini P, Sasso FC; COVOCA Study Group. Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study. PLoS One 2020;15:e0243700. [PMID: 33301529 DOI: 10.1371/journal.pone.0243700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
54 Concas G, Barone M, Francavilla R, Cristofori F, Dargenio VN, Giorgio R, Dargenio C, Fanos V, Marcialis MA. Twelve Months with COVID-19: What Gastroenterologists Need to Know. Dig Dis Sci 2021. [PMID: 34333726 DOI: 10.1007/s10620-021-07158-0] [Reference Citation Analysis]
55 Balaja WR 3rd, Jacob S, Hamidpour S, Masoud A. COVID-19 Presenting as Acute Icteric Hepatitis. Cureus 2021;13:e16359. [PMID: 34395136 DOI: 10.7759/cureus.16359] [Reference Citation Analysis]
56 Kirillov Y, Timofeev S, Avdalyan A, Nikolenko VN, Gridin L, Sinelnikov MY. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia. J Prim Care Community Health 2021;12:21501327211008050. [PMID: 33829916 DOI: 10.1177/21501327211008050] [Reference Citation Analysis]
57 Zhang Y, Zhao Y, Ren Q, Liu B, Shaikhet L. Characteristics Analysis of Incubation Time of COVID-19. Discrete Dynamics in Nature and Society 2022;2022:1-6. [DOI: 10.1155/2022/6500446] [Reference Citation Analysis]
58 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
59 Benedé-Ubieto R, Estévez-Vázquez O, Flores-Perojo V, Macías-Rodríguez RU, Ruiz-Margáin A, Martínez-Naves E, Regueiro JR, Ávila MA, Trautwein C, Bañares R, Bosch J, Cubero FJ, Nevzorova YA. Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain. J Clin Med 2021;10:1039. [PMID: 33802486 DOI: 10.3390/jcm10051039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Jha NK, Sharma C, Hashiesh HM, Arunachalam S, Meeran MN, Javed H, Patil CR, Goyal SN, Ojha S. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front Pharmacol 2021;12:590201. [PMID: 34054510 DOI: 10.3389/fphar.2021.590201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Napodano C, Pocino K, Stefanile A, Marino M, Miele L, Gulli F, Basile V, Pandolfi F, Gasbarrini A, Rapaccini GL, Basile U. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel. Scand J Immunol. 2021;93:e12977. [PMID: 32931622 DOI: 10.1111/sji.12977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases 2021; 9(3): 528-539 [PMID: 33553391 DOI: 10.12998/wjcc.v9.i3.528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
63 Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Oikonomou KG, Papamichalis P, Zafeiridis T, Xanthoudaki M, Papapostolou E, Valsamaki A, Bouliaris K, Papamichalis M, Karvouniaris M, Vlachostergios PJ, Skoura AL, Komnos A. Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions. World J Clin Cases 2021; 9(19): 4918-4938 [PMID: 34307544 DOI: 10.12998/wjcc.v9.i19.4918] [Reference Citation Analysis]
65 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
66 Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL;  Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. 2020;5:776-787. [PMID: 32585136 DOI: 10.1016/s2468-1253(20)30190-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
67 Warner FJ, Rajapaksha H, Shackel N, Herath CB. ACE2: from protection of liver disease to propagation of COVID-19. Clin Sci (Lond). 2020;134:3137-3158. [PMID: 33284956 DOI: 10.1042/cs20201268] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
68 Wang ZZ, Li K, Maskey AR, Huang W, Toutov AA, Yang N, Srivastava K, Geliebter J, Tiwari R, Miao M, Li XM. A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study. FASEB J 2021;35:e21360. [PMID: 33749932 DOI: 10.1096/fj.202001792R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Reference Citation Analysis]
70 Li R, Mao Z, Ye X, Zuo T. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms 2021;9:1017. [PMID: 34066850 DOI: 10.3390/microorganisms9051017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Valenti L, Griffini S, Lamorte G, Grovetti E, Uceda Renteria SC, Malvestiti F, Scudeller L, Bandera A, Peyvandi F, Prati D, Meroni P, Cugno M. Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19. J Autoimmun 2021;117:102595. [PMID: 33453462 DOI: 10.1016/j.jaut.2021.102595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
72 Campos MR, Schramm JMA, Emmerick ICM, Rodrigues JM, Avelar FG, Pimentel TG. Burden of disease from COVID-19 and its acute and chronic complications: reflections on measurement (DALYs) and prospects for the Brazilian Unified National Health System. Cad Saude Publica 2020;36:e00148920. [PMID: 33146278 DOI: 10.1590/0102-311X00148920] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol 2021;87:104647. [PMID: 33264669 DOI: 10.1016/j.meegid.2020.104647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
74 Park YJ, Farooq J, Cho J, Sadanandan N, Cozene B, Gonzales-Portillo B, Saft M, Borlongan MC, Borlongan MC, Shytle RD, Willing AE, Garbuzova-Davis S, Sanberg PR, Borlongan CV. Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics. Stem Cell Rev Rep 2021;17:9-32. [PMID: 32789802 DOI: 10.1007/s12015-020-10026-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
75 Vasques-Monteiro IML, Souza-Mello V. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. World J Gastroenterol 2021; 27(16): 1738-1750 [PMID: 33967554 DOI: 10.3748/wjg.v27.i16.1738] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Jounieaux V, Basille D, Abou-Arab O, Guillaumont MP, Andrejak C, Mahjoub Y, Rodenstein DO. Pure SARS-CoV-2 related AVDS (Acute Vascular Distress Syndrome). BMC Infect Dis 2021;21:122. [PMID: 33509109 DOI: 10.1186/s12879-021-05805-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
77 Muhović D, Bojović J, Bulatović A, Vukčević B, Ratković M, Lazović R, Smolović B. First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19. Liver Int 2020;40:1901-5. [PMID: 32478465 DOI: 10.1111/liv.14516] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
78 Lazova S, Alexandrova T, Gorelyova-Stefanova N, Atanasov K, Tzotcheva I, Velikova T. Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study. Microorganisms 2021;9:1958. [PMID: 34576853 DOI: 10.3390/microorganisms9091958] [Reference Citation Analysis]
79 Bohn MK, Lippi G, Horvath A, Sethi S, Koch D, Ferrari M, Wang CB, Mancini N, Steele S, Adeli K. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med 2020;58:1037-52. [PMID: 32459192 DOI: 10.1515/cclm-2020-0722] [Cited by in Crossref: 82] [Cited by in F6Publishing: 66] [Article Influence: 41.0] [Reference Citation Analysis]
80 Moore JT, Pilkington W, Kumar D. Diseases with health disparities as drivers of COVID-19 outcome. J Cell Mol Med 2020;24:11038-45. [PMID: 32816409 DOI: 10.1111/jcmm.15599] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
81 da Cunha MR, Rodrigues IC, Trigueiros F, Freitas LC, Braz S, Cota Medeiros F. A Case of Severe Acute Respiratory Syndrome Coronavirus 2 Treatment With Remdesivir in a Hepatitis C-Coinfected Patient Resulting in Temporary Viral Control and Posttreatment Flare. Open Forum Infect Dis 2021;8:ofab100. [PMID: 33880393 DOI: 10.1093/ofid/ofab100] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Gholami N, Amzajerdi VS, Mehdioghli R, Heris HK, Kazempour MJ. Isolated hyperbilirubinemia as the manifestation of acute liver failure in a patient with acute myelogenous leukemia and COVID-19 infection. Eur J Transl Myol 2021;31. [PMID: 34579517 DOI: 10.4081/ejtm.2021.9817] [Reference Citation Analysis]
83 Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, Fox AN, Zucker J, Verna EC. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort. Hepatology. 2020;72:807-817. [PMID: 32473607 DOI: 10.1002/hep.31404] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 47.0] [Reference Citation Analysis]
84 Vitale G, Gitto S, Marra F, Morelli MC. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic. Intern Emerg Med 2021. [PMID: 34245423 DOI: 10.1007/s11739-021-02801-0] [Reference Citation Analysis]
85 Hundt MA, Deng Y, Ciarleglio MM, Nathanson MH, Lim JK. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology. 2020;72:1169-1176. [PMID: 32725890 DOI: 10.1002/hep.31487] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 31.0] [Reference Citation Analysis]
86 Sonzogni A, Previtali G, Seghezzi M, Grazia Alessio M, Gianatti A, Licini L, Morotti D, Zerbi P, Carsana L, Rossi R, Lauri E, Pellegrinelli A, Nebuloni M. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations. Liver Int. 2020;40:2110-2116. [PMID: 32654359 DOI: 10.1111/liv.14601] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 31.0] [Reference Citation Analysis]
87 Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, Vander K, Bargfrieder U, Trauner M. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med 2020;173:350-61. [PMID: 32422076 DOI: 10.7326/M20-2566] [Cited by in Crossref: 303] [Cited by in F6Publishing: 225] [Article Influence: 151.5] [Reference Citation Analysis]
88 Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Viganò M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Lucà M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol 2020;73:1063-71. [PMID: 32526252 DOI: 10.1016/j.jhep.2020.06.001] [Cited by in Crossref: 93] [Cited by in F6Publishing: 110] [Article Influence: 46.5] [Reference Citation Analysis]
89 Guardigni V, Rosselli Del Turco E, Badia L, Galli S, Scolz K, Viale P, Verucchi G. Pre-Existing HBV and HCV Infections Do Not Affect COVID-19-Related Outcomes: An Observational Retrospective Study. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.116986] [Reference Citation Analysis]
90 Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in Children With Liver Disease. Front Pediatr 2021;9:616381. [PMID: 33777864 DOI: 10.3389/fped.2021.616381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Wong YJ, Tan M, Zheng Q, Li JW, Kumar R, Fock KM, Teo EK, Ang TL. A systematic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol 2020;19:627-34. [PMID: 32882393 DOI: 10.1016/j.aohep.2020.08.064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
92 Ponziani FR, Aghemo A, Cabibbo G, Masarone M, Montagnese S, Petta S, Russo FP, Lai Q; AISF COVID-19 survey group. Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey. Liver Int 2021;41:2228-32. [PMID: 34219343 DOI: 10.1111/liv.14998] [Reference Citation Analysis]
93 Silva FAFD, de Brito BB, Santos MLC, Marques HS, da Silva Júnior RT, de Carvalho LS, de Sousa Cruz S, Rocha GR, Correa Santos GL, de Souza KC, Maciel RGA, Lopes DS, Silva NOE, Oliveira MV, de Melo FF. Transmission of severe acute respiratory syndrome coronavirus 2 via fecal-oral: Current knowledge. World J Clin Cases 2021; 9(28): 8280-8294 [PMID: 34754839 DOI: 10.12998/wjcc.v9.i28.8280] [Reference Citation Analysis]
94 Yazdanpanah F, Garg A, Shadman S, Asmarz HY. Literature Review of COVID-19, Pulmonary and Extrapulmonary Disease. Am J Med Sci 2021;361:567-74. [PMID: 33785204 DOI: 10.1016/j.amjms.2021.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
95 Marabotto E, Ziola S, Sheijani AD, Giannini EG. COVID-19 and liver disease: Not all evil comes to harm. Liver Int 2021;41:237-8. [PMID: 33159405 DOI: 10.1111/liv.14721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Ye Z, Song B. COVID-19 Related Liver Injury: Call for International Consensus. Clin Gastroenterol Hepatol. 2020;18:2848-2851. [PMID: 32425707 DOI: 10.1016/j.cgh.2020.05.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
97 Abenavoli L, Gentile I, Maraolo AE, Negro F. SARS-CoV-2 and liver damage: a possible pathogenetic link. Hepatobiliary Surg Nutr. 2020;9:322-324. [PMID: 32509818 DOI: 10.21037/hbsn-20-437] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
98 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Sahin TT, Akbulut S, Yilmaz S. COVID-19 pandemic: Its impact on liver disease and liver transplantation. World J Gastroenterol 2020; 26(22): 2987-2999 [PMID: 32587443 DOI: 10.3748/wjg.v26.i22.2987] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
100 Hong JK, Chopra S, Kahn JA, Kim B, Khemichian S. Autoimmune hepatitis triggered by COVID-19. Intern Med J 2021;51:1182-3. [PMID: 34278694 DOI: 10.1111/imj.15420] [Reference Citation Analysis]
101 Lazarus JV, Negro F, El-Sayed M, Colombo M. A letter of solidarity during the COVID-19 pandemic. Liver Int 2020;40:2877-8. [PMID: 32526075 DOI: 10.1111/liv.14570] [Reference Citation Analysis]
102 Afify S, Eysa B, Hamid FA, Abo-Elazm OM, Edris MA, Maher R, Abdelhalim A, Abdel Ghaffar MM, Omran DA, Shousha HI. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 2021; 27(42): 7362-7375 [PMID: 34876795 DOI: 10.3748/wjg.v27.i42.7362] [Reference Citation Analysis]
103 Flaherty GT, Hession P, Liew CH, Lim BCW, Leong TK, Lim V, Sulaiman LH. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vaccines 2020;6:16. [PMID: 32868984 DOI: 10.1186/s40794-020-00118-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
104 Frater JL, Wang T, Lee YS. Laboratory hematologic features of COVID-19 associated liver injury: A systematic review. World J Meta-Anal 2021; 9(2): 193-207 [DOI: 10.13105/wjma.v9.i2.193] [Reference Citation Analysis]
105 Lima FB, Bezerra KC, Nascimento JCR, Meneses GC, Oriá RB. Risk Factors for Severe COVID-19 and Hepatitis C Infections: The Dual Role of Apolipoprotein E4. Front Immunol 2022;13:721793. [DOI: 10.3389/fimmu.2022.721793] [Reference Citation Analysis]
106 Vas V, North S, Rua T, Chilton D, Cashman M, Malhotra B, Garrood T. Delivering outpatient virtual clinics during the COVID-19 pandemic: early evaluation of clinicians' experiences. BMJ Open Qual 2022;11:e001313. [PMID: 34996810 DOI: 10.1136/bmjoq-2020-001313] [Reference Citation Analysis]
107 Balderramo D, Mattos AZ, Mulqui V, Chiesa T, Plácido-Damián Z, Abarca J, Bolomo A, Carlino Y, Bombassaro IZ, Wiltgen D, Castillo LT, Díaz K, Acuña J, Manero E, Prieto J, Carrera E, Díaz-Ferrer J, Debes JD. Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America. Can J Gastroenterol Hepatol 2021;2021:1622533. [PMID: 34621710 DOI: 10.1155/2021/1622533] [Reference Citation Analysis]
108 Muniangi-Muhitu H, Akalestou E, Salem V, Misra S, Oliver NS, Rutter GA. Covid-19 and Diabetes: A Complex Bidirectional Relationship. Front Endocrinol (Lausanne). 2020;11:582936. [PMID: 33133024 DOI: 10.3389/fendo.2020.582936] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
109 Lou Y, He X, Deng M, Hu X, Yang X, Liu L, Hu Y, He L, Wang J, Zhang L, Zhao Q, Lu X, Qiu Y. Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients. Front Med (Lausanne) 2021;8:626633. [PMID: 34307393 DOI: 10.3389/fmed.2021.626633] [Reference Citation Analysis]
110 Ali S, Prakash S, Murali AR. Hepatic Manifestations of Nonhepatotropic Infectious Agents Including Severe Acute Respiratory Syndrome Coronavirus-2, Adenovirus, Herpes Simplex Virus, and Coxiella burnetii. Gastroenterol Clin North Am 2021;50:383-402. [PMID: 34024447 DOI: 10.1016/j.gtc.2021.02.012] [Reference Citation Analysis]
111 D'Amico FE, Glavas D, Noaro G, Bassi D, Boetto R, Gringeri E, De Luca M, Cillo U. Case Report: Liver Cysts and SARS-CoV-2: No Evidence of Virus in Cystic Fluid. Front Surg 2021;8:677889. [PMID: 34222319 DOI: 10.3389/fsurg.2021.677889] [Reference Citation Analysis]
112 Zhou Y, Ding F, Bao W, Xue Y, Han L, Zhang X, Zhang P, Ji Y, Yin D, Bao A, Luo S, Xu Z, Liu J, Zhang M. Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. Ann Transl Med 2021;9:665. [PMID: 33987363 DOI: 10.21037/atm-21-445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
113 Ramachandran P, Perisetti A, Gajendran M, Chakraborti A, Narh JT, Goyal H. Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019. J Clin Exp Hepatol. 2020;10:533-539. [PMID: 32837096 DOI: 10.1016/j.jceh.2020.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
114 Magro F, Nuzzo A, Abreu C, Libânio D, Rodriguez-Lago I, Pawlak K, Hollenbach M, Brouwer WP, Siau K. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterol J 2021. [PMID: 34190413 DOI: 10.1002/ueg2.12115] [Reference Citation Analysis]
115 Verduyn M, Allou N, Gazaille V, Andre M, Desroche T, Jaffar MC, Traversier N, Levin C, Lagrange-Xelot M, Moiton MP, Hoang S. Co-infection of dengue and COVID-19: A case report. PLoS Negl Trop Dis 2020;14:e0008476. [PMID: 32745101 DOI: 10.1371/journal.pntd.0008476] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
116 Abd Allah M, Wahed S, Ammar I, Kamal E, Alboraie M, Abdel-Razek W, Hassany M, El-Serafy M, Waked I, Doss W. Utility of telemedicine in the treatment of patients with chronic HCV infection using DAAs in remote areas with limited resources. Liver Int 2021;41:1979-80. [PMID: 34153175 DOI: 10.1111/liv.14982] [Reference Citation Analysis]
117 Mousaad Elemam N, Hannawi H, Bin Naeem K, Hannawi S. A single centered study reveals association between liver injury and COVID-19 infection. Saudi J Biol Sci 2021. [PMID: 34220212 DOI: 10.1016/j.sjbs.2021.06.064] [Reference Citation Analysis]
118 Loganathan S, Kuppusamy M, Wankhar W, Gurugubelli KR, Mahadevappa VH, Lepcha L, Choudhary AK. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes. Respir Physiol Neurobiol 2021;283:103548. [PMID: 32956843 DOI: 10.1016/j.resp.2020.103548] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
119 Fabbri VP, Riefolo M, Lazzarotto T, Gabrielli L, Cenacchi G, Gallo C, Aspide R, Frascaroli G, Liguori R, Lodi R, Tonon C, D’errico A, Foschini MP. COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies. Biomolecules 2022;12:629. [DOI: 10.3390/biom12050629] [Reference Citation Analysis]
120 Chen LY, Chu HK, Bai T, Tu SJ, Wei Y, Li ZL, Hu LL, Zhu R, Zhang L, Han CQ, Xiao L, He Q, Song J, Liu WH, Zhu QJ, Chen H, Yang L, Hou XH. Liver damage at admission is an independent prognostic factor for COVID-19. J Dig Dis. 2020;21:512-518. [PMID: 32713118 DOI: 10.1111/1751-2980.12925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
121 Pousa PA, Mendonça TSC, Oliveira EA, Simões-E-Silva AC. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations. J Pediatr (Rio J) 2021;97:116-39. [PMID: 32980319 DOI: 10.1016/j.jped.2020.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
122 Bass A, Liu Y, Dakshanamurthy S. Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage. Viruses 2021;13:2418. [PMID: 34960687 DOI: 10.3390/v13122418] [Reference Citation Analysis]
123 Cantor A, Miller J, Zachariah P, DaSilva B, Margolis K, Martinez M. Acute Hepatitis Is a Prominent Presentation of the Multisystem Inflammatory Syndrome in Children: A Single-Center Report. Hepatology 2020;72:1522-7. [PMID: 32810894 DOI: 10.1002/hep.31526] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
124 Li T, Guo Y, Zhuang X, Huang L, Zhang X, Wei F, Yang B. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin. Saudi J Gastroenterol 2020;26:272-8. [PMID: 32769260 DOI: 10.4103/sjg.SJG_239_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
125 Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Reference Citation Analysis]
126 Uchida Y, Uemura H, Yamaba S, Hamada D, Tarumoto N, Maesaki S, Mochida S. Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19. J Gastroenterol. 2020;55:1098-1106. [PMID: 32776161 DOI: 10.1007/s00535-020-01717-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
127 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
128 Aghemo A, Masarone M, Montagnese S, Petta S, Ponziani FR, Russo FP;  Associazione Italiana Studio Fegato (AISF). Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver. Dig Liver Dis. 2020;52:937-941. [PMID: 32703730 DOI: 10.1016/j.dld.2020.07.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
129 Wiśniewska H, Skowron M, Bander D, Hornung M, Jurczyk K, Karpińska E, Laurans Ł, Socha Ł, Czajkowski Z, Wawrzynowicz-Syczewska M. Nosocomial COVID-19 Infection and Severe COVID-19 Pneumonia in Patients Hospitalized for Alcoholic Liver Disease: A Case Report. Am J Case Rep 2020;21:e927452. [PMID: 32973125 DOI: 10.12659/AJCR.927452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Wang J, Shu S, Zhang T, Zheng C. Chest CT findings in a pregnant woman in the second trimester with COVID-19 pneumonia. Clin Imaging 2021;69:266-8. [PMID: 33010733 DOI: 10.1016/j.clinimag.2020.07.021] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Yigit Y, Haddad M, Elmoheen A, Shogaa MR, Tawel R, Mohamed YK, Salem W, Fawzy Eltawagny M. Can COVID-19 Cause Flare-Ups of Acute Hepatitis B? An Atypical Presentation of COVID-19 with Acute Hepatitis B. Case Rep Infect Dis 2021;2021:8818678. [PMID: 33564481 DOI: 10.1155/2021/8818678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Medetalibeyoglu A, Catma Y, Senkal N, Ormeci A, Cavus B, Kose M, Bayramlar OF, Yildiz G, Akyuz F, Kaymakoglu S, Tukek T. The effect of liver test abnormalities on the prognosis of COVID-19. Ann Hepatol 2020;19:614-21. [PMID: 32920162 DOI: 10.1016/j.aohep.2020.08.068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
133 Suresh Kumar VC, Harne PS, Mukherjee S, Gupta K, Masood U, Sharma AV, Lamichhane J, Dhamoon AS, Sapkota B. Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study. World J Hepatol 2020; 12(9): 619-627 [PMID: 33033568 DOI: 10.4254/wjh.v12.i9.619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]